Researchers have been excited about Retatrutide , a groundbreaking dual compound showing significant data in initial trials for body loss . It functions by targeting both pathways : GLP-1 and GIP, https://mariamrazv316671.spintheblog.com/41105770/the-new-possibility-for-body-loss